CP-471474 is primarily recognized for its role in scientific research, particularly in studies focusing on cancer and neurodegenerative diseases. It functions as a selective inhibitor of matrix metalloproteinases (MMPs), enzymes that play a significant role in tissue remodeling and cancer progression. By inhibiting these enzymes, it helps researchers understand the mechanisms of tumor invasion and metastasis, providing insights into potential therapeutic strategies. Additionally, its application extends to studying the breakdown of the blood-brain barrier in neurological disorders, offering a tool to explore treatments for conditions like Alzheimer's disease and multiple sclerosis.